Civilization Ventures Management, Llc

Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.

Digital HealthHealthtechWellness & FitnessSan Francisco, US

Andrew DiMichelle(Executive Officer, Director)Adrian James(Executive Officer, Director)inSDSean Duffy(Executive Officer, Director)inWSWei-Li Shao(President)inSCSteve Cook(Chief Financial Officer)in

BoardJRJonathan Root(Director)in

Co-investorsAMaMoonANAndreessen HorowitzBLBlackbird GiantsCACanvas VenturesDEDesigner FundFOFounder Collective+14 more

Oxford Cancer Analytics develops a diagnostics platform that combines reproducible proteomic measurement with AI to produce evidence-based insights supporting clinical decision-making.

AI & Machine LearningBiotechMedical DevicesOxford, GB

AHAndreas Halner(Founder and Head of Healthcare AI)inHRHeinrich Roder(Chief Technology Officer)inDaniel Szulc(Chief Product Officer)in

Co-investorsEKEka VenturesCRCross-Border Impact VenturesMEMeridian Health VenturesUKUK Innovation & Science Seed FundDIDigitalDx VenturesONOnstage+1 more

10x provides an AI-powered back-office service that automates dental practice operations including hygiene recall outreach, treatment follow-up coordination, and missed-call answering.

AI & Machine LearningHealthtechSaaSSan Francisco, US

MBMax Bohun(Founder)in

Co-investorsY Y CombinatorINInitialized Capital

10x Science provides an AI platform that automates protein characterization for drug developers, reducing months of manual analysis to speed the evaluation of therapeutic candidates in early-stage development.

AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US

DRDavid Roberts(Founder and CEO)inARAndrew Reiter(Founder and COO)inVTVishnu Tejus(Founder and CTO)in

Co-investorsINInitialized CapitalY Y Combinator

23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery.

BiotechDigital HealthDirect to ConsumerHealthtechLongevityMountain View, US

AWAnne Wojcicki(Co-founder & CEO)inLinda Avey(Co-founder)Paul Cheung(Co-founder)Andrew Page(Executive Officer, Director)KHKathy Hibbs(Executive Officer)in

BoardEDEsther Dyson(Director)in

Co-investorsALAllied Venture PartnersEQEQUIAMFIFirebolt Ventures Management Company, LlcG G SquaredHOHouston Angel NetworkINInvestX+13 more

Adyn uses large inclusive datasets and machine learning to advance personalized medicine for historically under-researched health conditions, with initial focus on reproductive disorders.

AI & Machine LearningDigital HealthHealthtechMedical DevicesWellness & FitnessSeattle, US

ERElizabeth Ruzzo(Founder, CEO)inERElizabeth Ruzzo, PhD(Founder)in

Co-investorsASAscend Venture CapitalDUDuke Capital PartnersWEWestbound Equity PartnersY Y CombinatorM1M13

Aikium combines deep learning with large-scale wet-lab experimentation to design and screen protein libraries, aiming to develop protein therapeutics for hard-to-treat targets such as GPCRs and ion channels.

AI & Machine LearningBiotechDeep Tech

Eswar I(Founder)Venkatesh Mysore(Founder)inDr. Eswar Iyer(CEO | Head of Synthetic Biology)MTMichael Tolentino(Chief Development Officer)inDr. Shankar Shastry(Vice President | Head of Protein Sciences)

Co-investorsALAligned Health VenturesBABantam GroupFEFellows

Alveo Technologies makes a palm-sized molecular diagnostic analyzer with preloaded test cartridges that deliver on-site pathogen results in under an hour, with results sent to a smartphone.

AgTechBiotechMedical DevicesAlameda, US

RCRon Chiarello(Executive Officer, Director)inMichael Aicher(Executive Officer, Director)SHShaun Holt(Chairman of the Board & Chief Executive Officer)ETErik Tyrrell-Knott(President & Chief Business Officer)inScott(Chief Commercial Officer)SESlava Elagin(Executive (R&D/Operations))in

Co-investorsBLBlack Diamond VenturesCECelesta CapitalCECelesta CapitalPAPartners ResoluteSUSUPPLY CHANGE CAPITAL

Ample builds a modular battery-swapping technology that delivers a full charge to any electric vehicle in under five minutes using lego-like swappable battery modules, without requiring carmakers to redesign their cars.

CleantechEnergyMobility & Transportation

Co-investorsJAJazzya InvestmentsNENew Ground VenturesSTStart CapitalTRTransform Capital ManagementTRTRIRECXYXYZ Venture Capital+4 more

Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing.

Advanced ManufacturingBiotechHealthtechMenlo Park, US

CDChristina D. Smolke(Executive Officer, Director)inCSChristina Smolke(Co-Founder & CEO)inKHKristy Hawkins(Co-Founder & CSO)inEDEric d'Esparbes(Chief Financial Officer)inZMZack McGahey(Chief Operating Officer)inHPHeidi Pucel(Chief People Officer)in

Co-investorsAMAmerica's Frontier FundLALam CapitalSHSherpalo VenturesGLGlobal Health Investment Corporation

Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance.

AI & Machine LearningBiotechDeep TechAustin, US

Austin Cole(CEO & Founder)Guillaume Cottarel(Head of Program)inRDRussell Durrett(Chief Business Officer)

Co-investorsOMOMX VenturesAXAxial VCKDKdT Ventures

Aspect Biosystems develops bioprinted tissue therapeutics using a platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and biomaterials to create implantable allogeneic tissues.

AI & Machine LearningBiotechLongevity

TMTamer Mohamed(Founder & CEO)inSWSam Wadsworth(Co-founder & Chief Scientific Officer)inSBSimon Beyer(Co-founder & Chief Technology Officer)inLPLeela Paris(Chief Technical Operations Officer)inMSMike Scott(Chief Development Officer)inRSRay Smith(Chief Financial Officer)in

Co-investorsANAngel ForumINInBC Investment Corp.JDJDRF T1D FundPAPage One VenturesPAPallasite VenturesPAPangaea Ventures Us Inc.+5 more

Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.

BiotechDeep TechBoston, US

SVShane V. Hegarty(Chief Scientific Officer & Co-Founder)inJSJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJIJeff Imbaro(Chief Operating Officer)inTSTiasha Shafiq(Chief of Staff)in

BoardCorey . Goodman(Director)inJLJonathan Leff(Director)in

Co-investorsVEvenBio PartnersMRMRL Ventures FundSOSofinnova VenturesCRCreative Destruction Lab (CDL)HAHatteras Venture PartnersIAIaso Ventures+8 more

Babyscripts provides a maternity care platform with remote patient monitoring, risk screening, and care management services for pregnant and postpartum patients.

Digital HealthFemTechHealthtech

JPJuan Pablo Segura(Founder)inASAnish Sebastian(Founder & CEO)in

Co-investorsCUCU Healthcare Innovation FundMEMemorialCare Innovation FundPHPhilips VenturesBUBuilders + BackersIRIrishAngelsK K Street Capital+4 more

Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications.

Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsIrvine, US

Allen Barbieri(Executive Officer, Director)inDMDr. Matt Kriech(CEO)

BoardBernhard Mohr(Director)Meghan Sharp(Director)Kent Wasson(Director)Steve Bierschenk(Director)

Co-investorsHGHG VenturesATAthosGLGlobal Health Investment CorporationINIn-Q-TelSHSherpalo VenturesVIViking Global Investors

Biomemory develops DNA-based data storage systems for data centers, offering an alternative storage tier optimized for long-term archival, density, and energy efficiency.

Climate TechData & InfrastructureDeep Tech

Hyunjun Park(CEO)

Co-investorsFIFifty YearsHEHemisphere Ventures LLCNENew Enterprise Associates (NEA)PRPrefix CapitalZ Z Venture CapitalCACantos Ventures+3 more

Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors.

BiotechDeep TechHealthtechMedical DevicesSan Francisco, US

MLMarco Lobba(Founder)inMatthew Francis(Founder)in

Co-investorsCACALIFORNIA INNOVATIONCRCreative Destruction Lab (CDL)IAIaso VenturesMBMBX CapitalY Y CombinatorAXAxial VC+2 more

CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.

BiotechDeep TechHealthtechBerkeley, US

MLMarco Lobba, Ph.D.(Founder)in

Co-investorsFRFREEFLOWLOLongeVCCACaffeinated CapitalNYNYBC Ventures

Convergent Genomics is a genomic diagnostics company that uses next-generation sequencing and liquid biopsy to extract DNA from urine and detect, monitor, and predict urothelial (bladder) cancer non-invasively.

AI & Machine LearningBiotechDigital Health

Trevor Levin(Founder, President & Chief Scientific Officer)inBSBrian Slingerland(Chief Executive Officer)inBMBrian Mazzarella(Chief Medical Officer)IHIden Haddadzadeh(Chief Operating Officer)

Curai Health offers virtual primary care through a chat-based service, connecting patients with a care team of medical experts for diagnosis, treatment, prescription renewals, and management of conditions such as flu, hypertension, and diabetes.

AI & Machine LearningDigital HealthHealthtech

Co-investorsWEWestRiver Group

Curve Pay is a digital wallet that combines multiple bank cards into one, letting users switch which card paid for a purchase after the fact, avoid foreign exchange fees, and earn cashback on top of existing card rewards.

ConsumerFintech

SBShachar Bialick(Founder & CEO)in

Co-investorsCOCohen CircleFUFuel Venture CapitalHAHanaco Venture CapitalLILifeX VenturesMOMouro CapitalOUOutward VC+7 more

Delineate builds AI agents that help pharmaceutical companies design clinical trials more quickly by converting existing trial research into specialized datasets, reducing the time scientists spend on trial preparation.

AI & Machine LearningBiotechDeveloper ToolsEnterprise SoftwareSaaSBoston, US

ENEmily Nieves(Founder)inJIJawad Iqbal(Founder)in

Co-investorsY Y Combinator

DermBiont develops SM-030, a topical drug candidate targeting melasma, a skin pigmentation disorder, by inhibiting PKC-beta to address the underlying cause of hyperpigmentation.

BiotechDigital HealthMedical DevicesBoston, US

RBRobert Brucker(Executive Officer)inKRKarl R. Beutner(Executive Officer, Director)inNENichola Eliovits(Executive Officer, Director)inMDMax Dawson(Executive Officer)in

BoardWRWilder Ramsey(Director)inJennifer Lee(Director)

Co-investorsJOJoyance PartnersOLOlive Tree CapitalSTStart CapitalTOToba CapitalVAValia VenturesNENewpath Partners+1 more

One Health operates a clinical trial platform using canine cancer data to accelerate and de-risk human oncology drug development.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

CLChristina Lopes(Co-Founder & CEO)inBLBenjamin Lewis(Co-Founder)inCLchristina lopes(Founder)in

Co-investorsANAndreessen HorowitzAVaVentureGLGlobal BrainMAMaC Venture CapitalMYMyAsiaVCONOncology Ventures+5 more

Fluent Bio develops software for analyzing single-cell RNA sequencing data, producing count matrices and diagnostic outputs for researchers using Illumina sequencing libraries.

BiotechDeveloper Tools

Co-investorsCOCota CapitalILIllumina VenturesSASamsara BioCapital

Foresight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types.

BiotechDigital HealthHealthtechBoulder, US

Co-investorsAGAgent CapitalBOBoulder VenturesCUCU Healthcare Innovation FundFOForesite Capital

Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.

BiotechDeep TechBerkeley, US

DEDaniel Estandian(Founder)inEd Boyden(Founder)JYJosh Yang(Founder)in

BoardCACraig Asher(Director)inJimmy Yun(Director)in

Co-investorsARArtis VenturesBLBlack FlagFOFoundersX VenturesHAHarpoon VenturesLOLongeVCMOModi Ventures+5 more

Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.

BiotechHealthtechMedical DevicesElkins Park, US

Tsontcho Ianchulev(Executive Officer, Director)SISean Ianchulev(Founder & Chairman of the Board (CMO))inMichael Haydin(Executive Officer)

BoardJKJeffry K Weinhuff(Director)Farrell Tyson(Director)SBStephen Bloch(Director)in

Co-investorsAMaMoonVIVisionary VenturesCACanaan PartnersFEFemHealth VenturesJSJSD Capital, LLCUSUS Venture Partners

J.P.

Enterprise SoftwareFintechNew York City, US

Co-investors8V8VCBEBelief CapitalLULux CapitalSISilent VenturesSVSV AngelY Y Combinator

Infinimmune discovers and develops antibody therapeutics using proprietary sequencing technology and AI-powered optimization.

AI & Machine LearningBiotechMedical Devices

LHLance Hepler(Founder)inKPKatie Pfeiffer(Founder)inMichael Gibbons(Founder)inWMWyatt McDonnell(Founder)inDJdavid jaffe(Founder)in

Co-investorsPLPlayground GlobalAXAxial VCPAPaladin Capital GroupTRTrammell Venture Partners (TVP)

Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data.

AI & Machine LearningBiotechDeep TechChippendale, AU

TCTim Craven(CEO)inTPToby Passioura(CSO)inGlen McIntyre(COO)

BoardCOREY GOODMAN(Director)inMHMATT HERSHENSON(Director)in

Co-investorsBEBEVCMRMRL Ventures FundPLPlayground GlobalVEvenBio PartnersAXAxial VCVEvenBio Global Strategic

Integrated Biosciences is a biotech company developing small molecule therapeutics for age-related diseases, using optogenetics, chemistry, and AI to study aging biology.

AI & Machine LearningBiotechLongevityRedwood City, US

FWFelix Wong(Executive Officer, Director)inDJDaniel J. Anderson(Chief Scientific Officer)inThemasap Khan(Director)

BoardKeith Loebner(Director)

Co-investorsSUSutter Hill VenturesILIllumina Ventures

Invitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life.

BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

SGSean George(Executive Officer, Director)inRandal Scott(Executive Officer, Director)SGShelly Guyer(Executive Officer)inLBLee Bendekgey(Executive Officer)inGeoffrey Crouse(Director)

BoardEAEric Aguiar(Director)in

Co-investorsDEDecheng CapitalFIFifty YearsMAManta Ray VenturesOBOberland CapitalPRPrefix CapitalTETech Wildcatters+1 more

JustPaid is a B2B billing automation platform that uses AI to create, send, and track invoices, run collections, and reconcile payments across tools like Stripe, QuickBooks, Xero, and Salesforce.

AI & Machine LearningFintechSaaS

Co-investorsTRTRAC (Third Round Analytics Capital)DADating Group

Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

YEYusuf Erkul(Founder)inJOJeff Ozdemir(Founder)inBYBurak Yilmaz(Founder)inBYBurak YILMAZ(Founder)inCMCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)

Co-investorsASAsymmetry VenturesFOFoundersX VenturesHOHOF CapitalHUHummingbird VenturesSASAV (Scale Asia Ventures)Y Y Combinator+2 more

Lemonaid Health is a telehealth company that lets patients access medical care and treatment online from home, including services like contraceptive pill prescriptions and UTI treatment.

ConsumerDigital HealthDirect to ConsumerHealthtechSan Francisco, US

PJPaul Johnson(Founder)in

Co-investorsARArtis VenturesCOCorrelation VenturesDADaybreak PartnersEGeGateway CapitalFIFirebolt Ventures Management Company, LlcHIHikma Ventures+4 more

Manus Bio uses industrial biotechnology and engineered microbial cell factories to produce "BioAlternatives" — sustainable versions of molecules normally sourced from petrochemicals, agriculture, or animal husbandry — and offers a scale-up platform covering cell factory design through biomanufacturing.

BiotechFoodTechNew MaterialsAugusta, US

APAjikumar Parayil(Executive Officer, Director)inAPAji Parayil(Co-founder)inGreg Stephanopoulos(Co-founder)

BoardJWJason Whaley(Director)inCBCarsten Boers(Director)inRichard Goldstein(Director)

Co-investors+N+ND CapitalENEnergy Impact PartnersLILiebenthal VenturesNENelstone VenturesNXNXT VenturesPRPrefix Capital+2 more

Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy.

AI & Machine LearningBiotechDeep TechBoston, US

SMShashi Murthy(Executive Officer)inSean Kevlahan(Co-founder & CEO)inThomas Neenan(Co-founder & CBO)in

Co-investorsBABantam Group

Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.

BiotechDeep TechMedical DevicesSeattle, US

MLMarc Lajoie(Co-founder & Chief Executive Officer)inSBScott Boyken(Co-founder & Chief Technology Officer)inStanley Riddell(Co-Founder and Scientific Advisor)AFAaron Foster(Executive Officer)inCharity Scripture(Executive Officer)inESEric Soller(Executive Officer)in

Co-investorsARArtis VenturesRARA CapitalABAbstract VenturesATAtinum Investment Co. Ltd.MOModi VenturesPLPlayground Global+1 more

Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms.

AI & Machine LearningBiotechMedical DevicesNew York, US

Dr. Legut(Co-Founder and CEO)Dr. Sanjana(Co-Founder)Mateusz Legut(Executive Officer, Director)NSNeville Sanjana(Director)MLMat Legut(Founder)in

BoardVBVasudev Bailey(Director)in

Co-investorsARArtis VenturesFUFusionHAHAWKTAILWIWingALAlexandriaGAGaingels+1 more

This page is a distribution, marketing, and reseller partner directory for PRWeb, an online press release distribution service.

Marketing TechMedia & EntertainmentSaaS

Co-investorsADAdvance Venture PartnersANAngel Physicians FundAVAvestria VenturesAVAviv Venture CapitalBIBIGR VenturesBLBlue Venture Funds+15 more

Ermit designs and manufactures connected hardware devices with embedded software and AI capabilities, serving companies building IoT and field-operated products.

CybersecurityHardwareIoTNew York, IT

Emanuele Musini(CEO and Director)JWJames Wyman(CFO and Director)

BoardYogendra Jain(Director)

Co-investorsBIBioAdvanceHAHackensack Meridian Health Bear's DenHIHikma VenturesSASamsung VenturesSTStanley Ventures

Prellis Biologics runs an antibody discovery platform that uses two-photon laser-bioprinted human immune organoids combined with machine learning to identify fully human antibody therapeutics.

AI & Machine LearningBiotechDeep TechHayward, US

MMMelanie Matheu(Executive Officer, Director)NMNoelle Mullin(Executive Officer, Director)in

BoardArvind Gupta(Director)RSRohit Sharma(Director)in

Co-investorsBLBlack Diamond VenturesCECelesta CapitalCECelesta CapitalOPOpen Field CapitalPRPrefix CapitalCACantos Ventures+4 more

QUiCKR develops rapid genetic modification quantification kits for cell and gene therapy R&D programs, analyzing structural variants, edits, and genome integrity to accelerate development timelines and reduce costs.

BiotechDeep TechMedical Devices

CBCharles Blanluet(Founder)in

Co-investorsHCHCVCLELexi Ventures

Range Bio (Range Biotechnologies) develops next-generation diagnostics using translational proteomics for applications in human health.

BiotechHealthtechMedical Devices

Brandon Wilson, Ph.D.(Co-founder & CEO)BWBrandon Wilson(Co-founder & CEO)in

Co-investorsARArtis VenturesFIFifty YearsHAHAWKTAILPAPage One VenturesPEPear VCPIPillar

Gene editing company, with Civilization as founding investor, acquired by Intellia for $200M.

Co-investorsPRPrefix Capital

Rocket Pharmaceuticals develops gene therapies to treat patients with rare genetic diseases, focusing on cardiovascular and hematologic disorders.

BiotechDigital HealthMedical Devices

GSGaurav Shah(Co-founder & Chief Executive Officer)in

BoardRoderick Wong(Director)inNYNaveen Yalamanchi(Director)in

Co-investorsAVAvoro Capital AdvisorsBRBroadview VenturesRTRTW Investments L.P.

R-Zero provides AI software that reduces HVAC energy consumption in buildings by 20-40% using real-time occupancy and air quality data, with no infrastructure changes required.

CleantechEnterprise SoftwareIoT

Co-investorsDBDBL PartnersLELeadout CapitalQUQualcomm VenturesUPUpfront Ventures

Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

MGMiroslav Gasparek(Founder)inMKMarian Kupculak(Founder)in

BoardVishal Gulati(Director)Joel Schoppig(Director)

Co-investorsKAKAYARERecode VenturesY Y CombinatorZAZAKA VCBLBlueYard Capital

Siren Biotechnology develops next-generation AAV (adeno-associated virus) platforms for gene therapy applications, including gene repair, gene transfer, and gene editing.

BiotechDigital HealthMedical DevicesSan Francisco, US

Dr. Nicole Paulk(CEO, Founder, and President)inLKLauren Kelly(Founder)inSharon Tetlow(Director)Brad Allen(Director)

Co-investorsARArtis VenturesAVAvilaCACarnrite VenturesHAHAWKTAILNZNZVCPLPlum Alley Investments+2 more

Tahoe Bio AI applies machine learning and computational biology to drug discovery and development.

AI & Machine LearningBiotechDeep Tech

Co-investorsAIAIX VenturesAMAmplify PartnersWIWingDADatabricks Ventures

Teiko provides CLIA-validated high-dimensional cytometry services—including spectral flow and mass cytometry panels, blood preservation kits, gating, and a data analysis dashboard—for immune cell profiling in clinical trials.

BiotechDigital HealthHealthtechSalt Lake City, US

RSRamji Srinivasan(Executive Officer, Director)inMatt(Co-founder)inMatthew Spitzer(Director)

BoardVWVictor Wang(Director)in

Co-investorsHAHAWKTAILHOHOF CapitalTATau VenturesTWTwine VenturesWEWestern Technology Investment

TenSixty uses machine learning and cell biology expertise to identify novel antibody targets on cancer cells for the development of new cancer therapeutics.

AI & Machine LearningBiotechMedical DevicesCambridge, US

Daniel Montoro(Executive Officer, Director)inKarthik Jagadeesh(Executive Officer, Director)Christoph Muus(Director)

BoardDipchand Nishar(Director)SCSara Choi(Director)in

Co-investorsGEGeneral CatalystWIWing

Tigatx develops engineered IgA antibodies designed to engage neutrophils as a cancer treatment approach.

Biotech

Co-investorsBIBioGeneration Ventures

uLab Systems builds digital orthodontics tools, including software (uDesign, uAssist) and uSmile clear aligners manufactured in the USA, for dental professionals and orthodontic practices.

BiotechDigital HealthHealthtechMedical DevicesSaaSMemphis, US

AmirAli Talasaz(Director)Mark Foley(Director)David Thrower(Executive Officer)Tim Dumore(Director)Rita O'Connor(Director)Robert Doty(Executive Officer)

Co-investors7 7 Gate VenturesAPAPERTURE Venture PartnersTATachles VC

Verbal is an AI platform that audits healthcare interactions—including calls, video telemedicine, clinical notes, and chat—to ensure compliance with internal protocols and external standards like TJC and URAC.

AI & Machine LearningDigital HealthHealthtechSaaSCovina, US

Eric Lee Escobedo WuWMWaleed Mohsen

Co-investors50500 GlobalAUAUTHENTIC VENTURESCOCosmic Venture PartnersEAEast Post Road VenturesK2K20 FundTETechstars+1 more

Wild Earth manufactures plant-based dog food formulated to meet nutritional standards while reducing environmental impact compared to traditional meat-based pet food.

Circular EconomyConsumerFoodTechHealthtech

RBRyan Bethencourt(Founder)inRSRon Shigeta(Founder)inAbril Estrada(Founder)Kristin Wuhrman(Founder)

Co-investorsATAt One VenturesBABabel VenturesBIBig Idea VenturesBLBlue Horizon CorporationEVEvolution VC PartnersMAMaC Venture Capital+4 more

Wyndly provides personalized allergy treatment through board-certified doctors, delivering clinical immunotherapy and testing directly to patients' homes without requiring office visits.

Digital HealthHealthtechWellness & FitnessNew York City, US

ASAakash Shah(Founder, CEO)inMSManan Shah(Founder, Chief Medical Officer)in

Co-investorsIMImmeasurableY Y CombinatorGOGoodwater Capital